Overview

Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic Tests

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Phase IIB study to find the optimal dose rate range of propofol to maintain minimal-to-moderate sedation for diagnostic gastrointestinal endoscopy and gastrointestinal polypectomy.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Johnson & Johnson K.K. Medical Company
Treatments:
Propofol